Member Info for itsallamess

405 :)

There is our 4 quid!

Faron has always beed good at protecting their research.

"The US composition of matter patent covers bexmarilimab's binding sequences and Clever-1's corresponding epitope - specific elements of the antibody-antigen binding site. The expiry date, not including any potential extensions, is expected to be 2037"

I just wonder why the patent is only until 2037?

I wonder if the potential here is so important that they don't want to give exclusive rights to one company for too long?

With the low freefloat I should think we should be multiples of where we are now... however would love to be in the 4s

1 share trade.. RNS incoming?

Yes in finish. I wonder if it will have an impact on the naz stock price...

1 share trade, RNS incoming! :)

And who spent 232K on shares yesteday?

Just watched the interview again.. Some radom thoughts after

Looking forward to the follow up Q&A

RNS for 1st patient soon on hibiscus?

Did he say share price should be at least £5 if not £7 or £8 at the moment?

If markku was Sherlock Holmes, Moriarty is cortico steroids to him

They are still looking at the data for Bex on the increased doing results so we should get a RNS on that too I should think.

I reckon Timo got a heads up of good results before he spent nearly a million on new shares recently

Wouldnt be surprised to see a large price rerate soon

I wonder if a large pharma has already made an offer?

"When pressed on when they would do any deals - he repeated that they were so close to gaining this extra value from the new discoveries , that it would not be value for money for shareholders to be prematurely doing any deals yet "

Well done sax, your a credit to this board.

Makes you feel very confident about holding faron shares. Interesting about doing a deal and shareholder value. I've always thought that the faron team are not going to sell us out cheap for a quick buck but rather wait and we all get fair share.. (true value)

As for me I'm in no rush to get max value tomorrow.. This is a long term investment to pay for my older days..

Zumzum
I like it, Noble prize!

Now imagine the price tag for that on our shares!

Imagine if we could rove up Bex as a treatment for cancer without being in the pocket of a large pharma.

It seems like marrku always keeps us going without them!

Imagine the price tag on our shares if we stayed on our own!

Don't forget that the EU gave us a free grant toward bexmarilimab trials

I wonder as more results come in especially the fact marrku confirmed in the interview that Bex has a large market of treatable people as well as sure signs of prolonging life despite exhausting all other treatments including other immunotherapy.

I wonder if the EU would grant more money?

We should be at least in the 4 quid range.

With all the good news we consistently get,
the progress forward,
the lack of selling, the big shareholders Inc the BOD and company workers buying...

We are well over due a rerate 4.50 sounds good to me

Imagine selling up yesteday out of lack of patience:)

Covgaz, do you feel there is value here? I mean you could just sell up and move on! Or have you sold and was hoping for the stock to plummet to buy back in?

Good news this morning.

I didn't realise the size of this initial study, 141 paitents.

We have to remember that this phase of the study is about safety and tolerance of bexmarilimab /clevegen

And the results are good for that as are the results for extending life to paitents with some of these 10 hard to treat solid to tumors.

As Dan says below these are paitents who have exhausted all other options, been wreaked by all other treatments and then at their weakest stage they get Bex which has extended their life somewhat.

But yes once the satey/tolerance is finished we will know which 1of the 10 cohorts we Wil do the big trials on and I should imagine we may be the first line of treatment...

*These data demonstrate strong initial safety and tolerability, and promising anti-tumour activity in several refractory metastatic solid tumours - cutaneous melanoma, gastric cancer and cholangiocarcinoma - which helps us to determine in which cancer cohorts bexmarilimab offers the most promise. Together with the additional work underway investigating higher and more frequent dosing, biomarkers of efficacy and the potential for combination with earlier lines of therapy, we are building a clear path towards the next stage of the study."

https://m.facebook.com/fishingclub.fi/posts/2874204982622553?locale2=fr_FR
This is funny, if it's the same marrku, kicked out a Facebook fishing group!

4 months ago I was convinced a US listing would shoot us right up... But the past 3 months the US markets have been a mess.. Today its a bloodbath.. Accually its been a bloodbath for a while!

So I'm kinda thinking I hope we don't have anything to do with the US markets, they could just drag us down!